BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 7922998)

  • 1. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.
    Benvegnù L; Alberti A
    Antiviral Res; 2001 Nov; 52(2):199-207. PubMed ID: 11672830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study.
    Goritsas CP; Athanasiadou A; Arvaniti A; Lampropoulou-Karatza C
    J Clin Gastroenterol; 1995 Apr; 20(3):220-4. PubMed ID: 7797831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
    Benvegnù L; Alberti A
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses.
    Kato Y; Nakata K; Omagari K; Furukawa R; Kusumoto Y; Mori I; Tajima H; Tanioka H; Yano M; Nagataki S
    Cancer; 1994 Oct; 74(8):2234-8. PubMed ID: 7922974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
    Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
    Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
    Tsai JF; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Br J Cancer; 1997; 76(7):968-74. PubMed ID: 9328161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area.
    Lee HS; Han CJ; Kim CY
    Cancer; 1993 Nov; 72(9):2564-7. PubMed ID: 8402477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
    Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
    Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.
    Ishikawa T; Ichida T; Yamagiwa S; Sugahara S; Uehara K; Okoshi S; Asakura H
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1274-81. PubMed ID: 11903747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.
    Liu CJ; Chen PJ; Shau WY; Kao JH; Lai MY; Chen DS
    Liver Int; 2003 Jun; 23(3):148-55. PubMed ID: 12955877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.